Disclaimer: Any statements made about the properties of the axolotl or the field of regenerative medicine on this page are for educational purposes only and not meant to promote or explain the products of NeXtGen™ Biologics.
NeXtGen Biologics is an innovative medical device company developing a novel extracellular matrix (ECM) product with a pipeline of new technologies. Leveraging a world-class team with expertise in medical devices and breakthrough tissue technologies, the company will offer surgeons unique platform solutions that are transformative for patients and better manage a myriad of complex conditions seen in general surgery, trauma, cardiovascular diseases, neurosurgery, orthopedics and ophthalmology.
CureTech is a national provider of at-home recovery solutions that simplifies patient care through advanced compression therapy, digital prescribing workflows, and 24/7 patient support—helping providers improve outcomes while reducing administrative burden.
We support providers across ambulatory surgery centers, clinics, and rehabilitation settings with a full suite of recovery solutions, including DVT prevention, cryo-compression therapy, lymphedema management, and bone-growth stimulation.
Our integrated approach connects prescribing, delivery, and patient adherence—creating a seamless recovery experience from discharge to home.
That’s the CureTech Difference.
⸻
AWARDS
• 2025 #1 Supplier of the Year
• 2024 Best Places to Work
• 2024 #1 Supplier of the Year
• 2023 #2 Fastest Growing Company – KY
• 2023 #1 Supplier of the Year
• 2022 #2 Fastest Growing Company – KY
• 2022 #1 Supplier of the Year
TheraTest delivers tailored diagnostic testing designed to match your practice’s unique volume and revenue goals. Our expert team ensures a seamless process from start to finish, maximizing return without adding burden. Enhance your practice's net revenue by an average $60k-$100k per provider, per year.